A Novel Integrated Biomarker for Evaluation of Risk and Severity of Coronary Atherosclerosis, and Its Validation

Objective: To assess the feasibility of a combination of biochemical and imaging parameters for estimation of risk and severity of coronary atherosclerosis (CA), and to verify the created integrated biomarker (i-BIO) on independent cohort. Methods: Two cohorts of patients admitted to the hospital fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Metelskaya, Victoria A., Gavrilova, Natalia E., Zhatkina, Maria V., Yarovaya, Elena B., Drapkina, Oxana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877383/
https://www.ncbi.nlm.nih.gov/pubmed/35207694
http://dx.doi.org/10.3390/jpm12020206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877383/
https://www.ncbi.nlm.nih.gov/pubmed/35207694
http://dx.doi.org/10.3390/jpm12020206

Ejemplares similares